Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability

HARUHITO AZUMA, TERUO INAMOTO, KIYOSHI TAKAHARA, NAOKAZU IBUKI, KOHEI KOYAMA, SYNYA UTIMOTO, YUTAKA FUJISUE, HIROHUMI UEHARA, KAZUMASA KOMURA, HAYAHITO NOMI, TAKANOBU UBAI and YOJI KATSUOKA
Anticancer Research September 2010, 30 (9) 3737-3745;
HARUHITO AZUMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: uro004@poh.osaka-med.ac.jp
TERUO INAMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIYOSHI TAKAHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOKAZU IBUKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOHEI KOYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SYNYA UTIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTAKA FUJISUE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROHUMI UEHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUMASA KOMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAYAHITO NOMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANOBU UBAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOJI KATSUOKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Kaplan-Meier curves of progression-free survival (PFS) and overall survival (OS) for all patients.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
  • Table V.
  • Table VI.
PreviousNext
Back to top

In this issue

Anticancer Research: 30 (9)
Anticancer Research
Vol. 30, Issue 9
September 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability
HARUHITO AZUMA, TERUO INAMOTO, KIYOSHI TAKAHARA, NAOKAZU IBUKI, KOHEI KOYAMA, SYNYA UTIMOTO, YUTAKA FUJISUE, HIROHUMI UEHARA, KAZUMASA KOMURA, HAYAHITO NOMI, TAKANOBU UBAI, YOJI KATSUOKA
Anticancer Research Sep 2010, 30 (9) 3737-3745;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability
HARUHITO AZUMA, TERUO INAMOTO, KIYOSHI TAKAHARA, NAOKAZU IBUKI, KOHEI KOYAMA, SYNYA UTIMOTO, YUTAKA FUJISUE, HIROHUMI UEHARA, KAZUMASA KOMURA, HAYAHITO NOMI, TAKANOBU UBAI, YOJI KATSUOKA
Anticancer Research Sep 2010, 30 (9) 3737-3745;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire